Showing results (211-220 of 492) with videos related to
Sort By:
Pageof 50
Oncotarget|July 23, 2016
Osteosarcoma cells with genetic signatures of BRCAness are susceptible to the PARP inhibitor talazoparib alone or in combination with chemotherapeuticsFlorian Engert, Michal Kovac, Daniel Baumhoer, et al.Pediatric Nephrology (Berlin, Germany)|April 18, 2003
Macrophages induce apoptosis in proximal tubule cellsBärbel Lange-Sperandio, Simone Fulda, Alain Vandewalle, et al.EMBO Reports|January 23, 2019
Visualizing ubiquitination in mammalian cellsSjoerd Jl van Wijk, Simone Fulda, Ivan Dikic, et al.Cancer Letters|September 3, 2014
Synergistic interaction of Smac mimetic and IFNα to trigger apoptosis in acute myeloid leukemia cellsVanessa Bake, Stefanie Roesler, Ines Eckhardt, et al.Oncogene|June 3, 2018
BCL-2 selective inhibitor ABT-199 primes rhabdomyosarcoma cells to histone deacetylase inhibitor-induced apoptosisUlrike Heinicke, Tinka Haydn, Sarah Kehr, et al.Cancer Letters|May 24, 2020
The novel dual BET/HDAC inhibitor TW09 mediates cell death by mitochondrial apoptosis in rhabdomyosarcoma cellsStephanie Laszig, Cathinka Boedicker, Tim Weiser, et al.International Journal of Cancer|June 8, 2019
Targeting ferroptosis in rhabdomyosarcoma cellsJasmin Dächert, Vanessa Ehrenfeld, Karoline Habermann, et al.Frontiers in Oncology|July 10, 2015
Oncogenic RAS Mutants Confer Resistance of RMS13 Rhabdomyosarcoma Cells to Oxidative Stress-Induced Ferroptotic Cell DeathChristina Schott, Ulrike Graab, Nicole Cuvelier, et al.Cancer Letters|October 13, 2018
Identification of Smac mimetics as novel substrates for p-glycoproteinManuela Hugle, Sebastian Czaplinski, Karoline Habermann, et al.Cell Death & Disease|October 6, 2017
Targeting redox homeostasis in rhabdomyosarcoma cells: GSH-depleting agents enhance auranofin-induced cell deathKaroline Johanna Habermann, Leon Grünewald, Sjoerd van Wijk, et al.Pageof 50